News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

December 3, 2019
Appili Therapeutics Enters Commercial Agreement With Saptalis Pharmaceuticals for Anticipated Launch of ATI-1501 Antibiotic Candidate in the U.S.
December 2, 2019
Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer
December 2, 2019
Appili Therapeutics Names Dr. Armand Balboni as Chief Executive Officer
November 27, 2019
Appili Therapeutics Reports Financial Results for Second Quarter of Fiscal Year 2020
November 21, 2019
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical